EPISODE · Apr 9, 2026 · 21 MIN
Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies
from VJHemOnc Podcast · host VJHemOnc
This episode reviews major advances presented at the EBMT 2026 meeting in Madrid, covering novel treatments for acute and chronic GVHD, including a promising microbiome-based therapy, and new targeted agents. Experts discuss the growing importance of donor germline genetics, updated guidance for Hodgkin lymphoma transplantation, the shifting role of CAR T‑cell therapy in non‑Hodgkin lymphoma, and how measurable residual disease (MRD) is shaping transplant decisions and post‑transplant care. Overall, the episode highlights how these developments are improving personalization and outcomes in haemopoietic stem cell transplantation.
What this episode covers
This episode reviews major advances presented at the EBMT 2026 meeting in Madrid, covering novel treatments for acute and chronic GVHD, including a promising microbiome-based therapy, and new targeted agents.Experts discuss the growing importance of donor germline genetics, updated guidance for Hodgkin lymphoma transplantation, the shifting role of CAR T‑cell therapy in non‑Hodgkin lymphoma, and how measurable residual disease (MRD) is shaping transplant decisions and post‑transplant care.Overall, the episode highlights how these developments are improving personalization and outcomes in haemopoietic stem cell transplantation.
NOW PLAYING
Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m